ADIPOQ and obesity disorder: It has been found that adiponectin plasma concentrations are lower in individuals with CAD compared to age- and obesity-matched controls [80] and that individuals with adiponectin levels under 4 μg/ml were at increased risk of CAD and presented more factors for MS [81].